Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.concorddrugs.in | |
Market Cap | 27.81 Cr. | |
Enterprise Value(EV) | 45.01 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.94 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 33.99 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.78 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 32.86 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 0.97 | Calculated using Price: 31.80 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.87 Cr. | 8,743,750 Shares |
FaceValue | 10 | |
Company Profile | ||
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. |
1 Day |
|
+1.92% |
1 Week |
|
+1.27% |
1 Month |
|
-2.30% |
3 Month |
|
+1.60% |
6 Month |
|
+26.69% |
1 Year |
|
-7.42% |
2 Year |
|
+30.60% |
5 Year |
|
+5.82% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.72 | 5.37 | 12.32 | 0.94 | 1.69 | 1.92 | 1.41 | 13.06 | 5.78 | |
Return on Capital Employed (%) | 7.15 | 11.33 | 15.90 | 8.84 | 7.49 | 6.17 | 6.06 | 15.69 | 9.30 | |
Return on Assets (%) | 0.79 | 1.41 | 3.28 | 0.30 | 0.40 | 0.43 | 0.47 | 6.08 | 3.00 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 15 | 13 | 15 | 19 | 19 | 23 | 23 | 27 | 28 | 29 | |
Non Curr. Liab. | 12 | 13 | 17 | 7 | 6 | 4 | 7 | 7 | 5 | 5 | |
Curr. Liab. | 18 | 28 | 21 | 29 | 81 | 56 | 27 | 16 | 23 | 20 | |
Minority Int. | |||||||||||
Equity & Liab. | 45 | 54 | 52 | 56 | 106 | 83 | 58 | 50 | 56 | 54 | |
Non Curr. Assets | 21 | 19 | 16 | 25 | 14 | 13 | 12 | 14 | 15 | 14 | |
Curr. Assets | 23 | 36 | 37 | 30 | 92 | 70 | 46 | 36 | 42 | 40 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 45 | 54 | 52 | 56 | 106 | 83 | 58 | 50 | 56 | 54 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 34 | 40 | 51 | 57 | 52 | 48 | 51 | 51 | 59 | 55 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total Income | 34 | 40 | 51 | 58 | 52 | 48 | 51 | 51 | 59 | 55 | |
Total Expenditure | -31 | -33 | -42 | -52 | -47 | -44 | -48 | -48 | -53 | -51 | |
PBIDT | 3 | 7 | 8 | 6 | 5 | 4 | 3 | 3 | 6 | 4 | |
Interest | -2 | -3 | -3 | -2 | -2 | -2 | -2 | -1 | -2 | -1 | |
Depreciation | -1 | -4 | -3 | -3 | -2 | -2 | -1 | -1 | -2 | -2 | |
Taxation | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | |
Exceptional Items | 4 | ||||||||||
PAT | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 3 | 2 | 1 | |
Adjusted EPS | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 4 | 2 | 1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 2 | 2 | 4 | 2 | 7 | 1 | 2 | 2 | 1 | |
Cash Fr. Inv. | -10 | -2 | -1 | 0 | -1 | -2 | 0 | -1 | -4 | 0 | |
Cash Fr. Finan. | 8 | 0 | -1 | -4 | -4 | -5 | -1 | -2 | 2 | 2 | |
Net Change | -1 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 2 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 3 |
Thu, 12 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance certificate under reg 74 (5) |
Tue, 27 Dec 2022
Closure of Trading Window Closure of trading window for the quarter ended 31.12.2022 |
Mon, 28 Nov 2022
Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (LODR) Regulations 2015 For The Half Year Ended 30.09.2022 Disclosure of Related Party Transactions under Regulation 23(9) of SEBI (LODR) Regulations 2015 for the half year ended 30.09.2022 |
Mon, 30 Jan 2023 |
|
|
|
|
|